Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia
Jonathan G. Seidman(Harvard University), Ronny Alcalai(Harvard University), Michael Arad(Tel Aviv University), Okan Toka(Harvard University), Cordula M. Wolf(Friedrich-Alexander-Universität Erlangen-Nürnberg), Charles I. Berul(Children's National), David A. Conner(Howard Hughes Medical Institute), Christine E. Seidman(Harvard University), Michael Eldar(Sheba Medical Center)
Cited by 185
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Cells of the adult human heart
|Nature|2020|1.8k